CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00231751
NCT00231751N/ACompleted
CompareCT.gov

The Malmö International Brother Study (MIBS)

Skane University Hospital·observational·Posted Oct 4, 2005·Updated Oct 4, 2005

In Brief

An observational study for Hemophilia A With Inhibitors. Completed, across 1 site.

Detailed Summary

Existing data support the concept that a genetic predisposition for inhibitor development exists. The aim of the Malmö International Brother Study (MIBS) is to evaluate genetic factors associated with the development of inhibitory antibodies in patients with hemophilia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemophilia A With Inhibitors
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 4, 2005
Enrollment StartNov 1, 2002
Study CompletionJun 1, 2004
TodayJul 2, 2026
Posted 20.7 years ago